Phenylimidazolidines having antiandrogenic activity

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514391, 514342, 5483111, 5483171, 5483185, 5483201, 5483205, C07D23372, A61K 31415

Patent

active

054119812

ABSTRACT:
A compound of the formula ##STR1## wherein R.sub.1 is --CN, --NO.sub.2 or halogen, R.sub.2 is --CF.sub.3 or halogen, --A-B-- is of ##STR2## X is --O-- or --S--, R.sub.3 is hydrogen, alkyl, alkenyl or alkynyl of up to 12 carbon atoms, aryl and aralkyl of up to 12 carbon atoms, all optionally substituted by --OH, halogen, --SH, --CN, acyl and acyloxy of up to 7 carbon atoms, --aryl, --O--aryl, --O--aralkyl --S-- aryl of up to 12 carbon atoms the aryl and aralkyl being optionally substituted by halogen, --CF.sub.3, alkyl, alkoxy, alkenyl, alkenyloxy, alkynyl or alkynyloxy with the sulfur being optionally oxidized to sulfone or sulfoxide, free, esterified, amidified or salified carboxy, --NH.sub.2, mono and dialkylamino and heterocyclic of 3 to 6 ring members and containing at least one heteroatom selected from the group consisting of oxygen, sulfur and nitrogen, the alkyl, alkenyl and alkynyl being optionally interrupted by at least one oxygen, nitrogen or sulfur optionally oxidized to sulfoxide or sulfone, trialkylsilyl with the alkyl having 1 to 6 carbon atoms and acyl and acyloxy of an organic carboxylic acid of 1 to 7 carbon atoms and Y is --O--, --S-- or --NH--, except the compounds wherein --A-B-- is ##STR3## X is oxygen, R.sub.3 is hydrogen and Y is oxygen or --NH--, R.sub.2 is --CF.sub.3 or halogen and R.sub.1 is --NO.sub.2 or halogen and their non-toxic, pharmaceutically acceptable acid addition salts.

REFERENCES:
patent: 3823240 (1974-07-01), Sauli et al.
patent: 4097578 (1978-06-01), Perronet et al.
patent: 4234736 (1980-11-01), Bernauer et al.
patent: 4304782 (1981-12-01), Dymont et al.
patent: 4407814 (1983-10-01), Bernauer et al.
patent: 4427438 (1984-01-01), Nagano et al.
patent: 4473393 (1984-10-01), Nagpal
patent: 4482739 (1984-11-01), Bernauer et al.
patent: 4749403 (1988-06-01), Liebl et al.
patent: 4859228 (1989-08-01), Prisbylla
patent: 4873256 (1989-10-01), Coussediere et al.
patent: 4944791 (1990-07-01), Schroder et al.
patent: 5069711 (1991-12-01), Fischer et al.
Raynaud et al., J. Steriod Biochem., vol. 11, pp. 93-99 (1979).
Rao et al., J. Steriod Biochem., vol. 31, pp. 731-737 (1988).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Phenylimidazolidines having antiandrogenic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenylimidazolidines having antiandrogenic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylimidazolidines having antiandrogenic activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1137369

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.